Medical cartel is strangling US healthcare market

Extremely informative article from FEE: The Medical Cartel is Keeping Health Care Costs High:

“Though few Americans realize it, health care is a monopoly. In the early 20th century, the American Medical Association (AMA) lobbied the Federal government to close all schools not approved by its own Council on Medical Education. They unfortunately succeeded and 30 percent of medical schools were closed within 30 years. The number of doctors has been artificially capped ever since.

The AMA also controls state boards of licensing, limiting the number of physicians in each state and preventing competitors from treating patients. The United States has 50 percent fewer practicing physicians per capita than Sweden or Germany. Unsurprisingly, US doctors also work fewer hours while earning much higher salaries…

…Similar federal regulatory monopolies prevent generic drugs from competing with big brands, block the building of new health care facilities, and limit health insurers to two or three per state. Our health care options shrink as special interests’ regulatory control grows resulting in fewer drugs, fewer doctors, fewer plans, and fewer choices.”

Read the entire piece.

US is funding regime change in Venezuela

Secretary of State Rex Tillerson recently openly threatened regime change for Venezuela’s Maduro, but the US goal of regime change for the South American country is nothing new.

The US gov’t has set aside at least $49 million for regime for opposition groups in the country since 2009, along with $4 million in funding to Venezuelan journalists between 2007 and 2009.

If US experience with past attempts at regime change are any indication, the result will be the same as it’s been in Iraq, Libya, Afghanistan, and the rest of the Middle East: destabilization, millions dead, millions more displaced, a country-wide dumpster fire, and another generation of foreigners wishing death upon US citizens.

See also Salon: This Is Why They Hate Us

Psilocybin the most effective, and least dangerous, antidepressant

Dope Magazine:

“The psychological effects of psilocybin were not only positive, but enduring. Most participants ranked the experience among the most meaningful of their lives, and six months after taking the dose, 65 percent had almost fully recovered from their depression, and 57 percent from their anxiety. In contrast, antidepressants have been observed to help only 40 percent of terminal cancer patients in past studies—making them about as effective as a placebo…

Indeed, the lasting effects of psilocybin and LSD, as observed in Griffiths’ study and others, can help anyone, not just those struggling with cancer or clinical depression. Neither drug has much potential for addiction, and the only significant associated risks are from accidents or anxiety attacks, which can be particularly damaging for users with schizophrenia or bipolar disorder. Researchers screened participants for such risk factors and provided a safe, encouraging environment for their trips.”